Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

PDSB

Live52w high -40.7%

Loading latest news…

Log in Get Started

☁️ News word cloud

Top words across the last 50 articles for this ticker.

2023biotechcancerbiotechnologynasdaqclinicalannouncedresultsphasetrialinfectiousdiseasestagegrowingpipelineimmunotherapyglobenewswiredevelopingtargeted

Loading latest news…

52w high -40.7%

☁️ News word cloud

Top words across the last 50 articles for this ticker.

2023biotechcancerbiotechnologynasdaqclinicalannouncedresultsphasetrialinfectiousdiseasestagegrowingpipelineimmunotherapyglobenewswiredevelopingtargeted